Guinea-Bissau vs Mauritania: Share of children with symptoms of a respiratory infection who received antibiotics
Guinea-Bissau
23.7%
in 2018
Mauritania
23.0%
in 2018
Guinea-Bissau rank
131st
Mauritania rank
132nd
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Guinea-Bissau
- Mauritania
How they compare
Guinea-Bissau currently reports 23.7% against 23.0% in Mauritania, a difference of 0.7%.
Across all 19 years both countries report, Guinea-Bissau has been ahead every year.
Guinea-Bissau ranks 131st and Mauritania ranks 132nd of 132 countries.
Guinea-Bissau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.3% | 23.3% | 9.0% | Guinea-Bissau |
| 2010s | 34.5% | 27.4% | 7.1% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Guinea-Bissau or Mauritania?
- Guinea-Bissau, at 23.7% against 23.0% in Mauritania as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Guinea-Bissau and Mauritania?
- 0.7%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Mauritania?
- 19 years are reported by both, from 2000 to 2018.
- How do Guinea-Bissau and Mauritania rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Guinea-Bissau ranks 131st and Mauritania ranks 132nd of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.